FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,607 | -69.8% | 54,531 | -32.1% | 0.00% | – |
| Q2 2023 | $382,286 | -79.9% | 80,312 | -76.0% | 0.00% | -100.0% |
| Q1 2023 | $1,906,136 | +57.7% | 334,410 | +179.2% | 0.00% | – |
| Q4 2022 | $1,208,722 | -49.9% | 119,794 | +11.3% | 0.00% | -100.0% |
| Q3 2022 | $2,412,000 | -20.1% | 107,662 | -11.6% | 0.00% | 0.0% |
| Q2 2022 | $3,019,000 | -26.8% | 121,817 | +14.6% | 0.00% | 0.0% |
| Q1 2022 | $4,123,000 | -30.5% | 106,340 | +4.9% | 0.00% | -50.0% |
| Q4 2021 | $5,934,000 | +6.0% | 101,421 | +7.4% | 0.00% | 0.0% |
| Q3 2021 | $5,596,000 | +13.2% | 94,424 | +65.8% | 0.00% | 0.0% |
| Q2 2021 | $4,944,000 | +16.4% | 56,964 | +10.5% | 0.00% | 0.0% |
| Q1 2021 | $4,249,000 | -10.9% | 51,538 | -1.7% | 0.00% | 0.0% |
| Q4 2020 | $4,768,000 | +151.7% | 52,430 | +10.7% | 0.00% | +100.0% |
| Q3 2020 | $1,894,000 | +143.4% | 47,378 | +109.1% | 0.00% | – |
| Q2 2020 | $778,000 | +58.5% | 22,657 | +2.6% | 0.00% | – |
| Q1 2020 | $491,000 | -19.0% | 22,076 | -28.7% | 0.00% | – |
| Q4 2019 | $606,000 | +43.3% | 30,973 | +13.7% | 0.00% | – |
| Q3 2019 | $423,000 | +94.0% | 27,232 | +153.7% | 0.00% | – |
| Q2 2019 | $218,000 | +5.8% | 10,732 | -8.5% | 0.00% | – |
| Q1 2019 | $206,000 | +41.1% | 11,732 | +3.1% | 0.00% | – |
| Q4 2018 | $146,000 | +16.8% | 11,376 | +48.6% | 0.00% | – |
| Q3 2018 | $125,000 | +43.7% | 7,657 | 0.0% | 0.00% | – |
| Q2 2018 | $87,000 | +4.8% | 7,657 | -10.4% | 0.00% | – |
| Q1 2018 | $83,000 | +72.9% | 8,543 | +9.7% | 0.00% | – |
| Q4 2017 | $48,000 | +118.2% | 7,785 | +38.4% | 0.00% | – |
| Q3 2017 | $22,000 | +22.2% | 5,627 | 0.0% | 0.00% | – |
| Q2 2017 | $18,000 | – | 5,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |